430 related articles for article (PubMed ID: 11886482)
1. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma.
Nousiainen T; Jantunen E; Vanninen E; Remes J; Vuolteenaho O; Hartikainen J
Eur J Haematol; 1999 Feb; 62(2):135-41. PubMed ID: 10052718
[TBL] [Abstract][Full Text] [Related]
3. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
[TBL] [Abstract][Full Text] [Related]
4. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
[TBL] [Abstract][Full Text] [Related]
5. N-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy.
Fruhwald FM; Fahrleitner A; Watzinger N; Dobnig H; Schumacher M; Maier R; Zweiker R; Leb G; Klein W
Heart; 1999 Nov; 82(5):630-3. PubMed ID: 10525523
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular systolic/diastolic function evaluated by quantitative ECG-gated SPECT: comparison with echocardiography and plasma BNP analysis.
Nakae I; Matsuo S; Koh T; Mitsunami K; Horie M
Ann Nucl Med; 2005 Sep; 19(6):447-54. PubMed ID: 16248380
[TBL] [Abstract][Full Text] [Related]
7. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
Vasan RS; Benjamin EJ; Larson MG; Leip EP; Wang TJ; Wilson PW; Levy D
JAMA; 2002 Sep; 288(10):1252-9. PubMed ID: 12215132
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer.
Hayakawa H; Komada Y; Hirayama M; Hori H; Ito M; Sakurai M
Med Pediatr Oncol; 2001 Jul; 37(1):4-9. PubMed ID: 11466716
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients.
Nousiainen T; Vanninen E; Jantunen E; Remes J; Ritanen E; Vuolteenaho O; Hartikainen J
Clin Sci (Lond); 2001 Dec; 101(6):601-7. PubMed ID: 11724646
[TBL] [Abstract][Full Text] [Related]
10. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
Loke I; Squire IB; Davies JE; Ng LL
Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
[TBL] [Abstract][Full Text] [Related]
11. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
[TBL] [Abstract][Full Text] [Related]
12. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
[TBL] [Abstract][Full Text] [Related]
13. Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer.
Pongprot Y; Sittiwangkul R; Charoenkwan P; Silvilairat S
J Pediatr Hematol Oncol; 2012 Nov; 34(8):589-95. PubMed ID: 23018571
[TBL] [Abstract][Full Text] [Related]
14. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
[TBL] [Abstract][Full Text] [Related]
15. Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
Kuittinen T; Jantunen E; Vanninen E; Mussalo H; Vuolteenaho O; Ala-Kopsala M; Nousiainen T; Hartikainen J
Eur J Haematol; 2006 Aug; 77(2):120-7. PubMed ID: 16856907
[TBL] [Abstract][Full Text] [Related]
16. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
Bakowski D; Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
Fruhwald FM; Fahrleitner A; Watzinger N; Fruhwald S; Dobnig H; Schumacher M; Maier R; Zweiker R; Klein WW
Eur Heart J; 1999 Oct; 20(19):1415-23. PubMed ID: 10487802
[TBL] [Abstract][Full Text] [Related]
18. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction.
Tulevski II; Groenink M; van Der Wall EE; van Veldhuisen DJ; Boomsma F; Stoker J; Hirsch A; Lemkes JS; Mulder BJ
Heart; 2001 Jul; 86(1):27-30. PubMed ID: 11410557
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction].
Uetake S; Takahashi M; Tamano K; Honda T; Kobayashi T; Horinaka S
J Cardiol; 2001 Aug; 38(2):61-71. PubMed ID: 11525111
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
Ikeda N; Yasu T; Nishikimi T; Nakamura T; Kubo N; Kawakami M; Momomura S; Saito M
Regul Pept; 2007 Jun; 141(1-3):154-8. PubMed ID: 17292492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]